To tackle this challenge, we tested whether we could generate lung progenitor cells (LPCs) accurately recapitulating the characteristics of RET-rearranged NSCLC from a patient-derived iPSC carrying the RETC634Y point mutation. The gene discussed is RET; the disease is non-small cell lung carcinoma.